Profusa Stock Price, News & Analysis

Profusa, Inc. is a publicly traded company whose securities are registered under the Securities Exchange Act of 1934. While the NVACW symbol refers to warrants associated with Profusa, Inc., the company’s common stock trades under the symbol PFSA on The Nasdaq Stock Market LLC, as disclosed in multiple current reports on Form 8-K and other SEC filings. Profusa, Inc. is identified in SEC documents as an emerging growth company and a registrant with reporting obligations under Sections 13 or 15(d) of the Exchange Act.

According to its filings, Profusa, Inc. has entered into various financing arrangements, including a Securities Purchase Agreement and related senior secured convertible promissory notes with Ascent Partners Fund LLC and other purchasers. These agreements, as described in the company’s Form 8-K reports, provide for the issuance and sale of common stock and convertible notes, subject to conditions such as registration of conversion shares, floor price provisions, and mandatory prepayment terms tied to subsequent offerings.

Profusa, Inc. has also called a special meeting of stockholders, as detailed in its definitive proxy statement on Schedule 14A. The proxy materials explain that the special meeting is being held to consider proposals including a reverse stock split of the company’s common stock within a specified ratio range, the ratification of the appointment of an independent registered public accounting firm, and the potential adjournment of the meeting to solicit additional proxies if needed. The proxy statement outlines that only holders of record of the company’s common stock as of a stated record date are entitled to vote at the special meeting.

The company has reported that it is an emerging growth company and has, at times, utilized the extended transition period for complying with new or revised financial accounting standards, as indicated by the emerging growth company checkboxes in its Form 8-K filings. Profusa, Inc. has also filed a Form 12b-25 (Notification of Late Filing) indicating that it required additional time to finalize disclosures for a Quarterly Report on Form 10-Q and expected to file that report within the permitted extension period. In that notification, the company confirmed that it did not anticipate a significant change in results of operations compared to the corresponding period of the prior year.

In an 8-K filed under Item 3.01, Profusa, Inc. disclosed that it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market stating that the company was not in compliance with the continued listing requirement to maintain a minimum market value of publicly held shares for the Nasdaq Global Market. The filing explains that this notice did not have an immediate effect on the listing or trading of the company’s common stock and that the company was granted a compliance period to regain compliance with the applicable Nasdaq listing rule.

Across its filings, Profusa, Inc. provides information about its capital structure, including the number of outstanding shares of common stock as of a record date, and describes the mechanics of its financing arrangements, such as floor price definitions, volume-weighted average price (VWAP) based conversion pricing, and conditions for additional tranches of funding. These disclosures are relevant for investors analyzing both the common stock (PFSA) and related securities such as warrants trading under symbols like NVACW.

Profusa, Inc. and the NVACW warrants

The NVACW ticker represents warrants linked to Profusa, Inc. While the SEC filings reproduced here focus primarily on the issuer and its common stock, they provide important context for warrant holders, including information on reverse stock split proposals, potential changes in capital structure, and Nasdaq listing compliance matters. Because warrant values are typically sensitive to the underlying common stock’s trading status and capital transactions, the company’s proxy statements, 8-K reports, and other periodic filings are key reference points for understanding the environment in which the NVACW warrants exist.

Corporate governance and stockholder actions

The definitive proxy statement for the special meeting of stockholders describes how Profusa, Inc. conducts stockholder meetings, including the use of a virtual meeting format that allows stockholders of record and beneficial owners, through appropriate proxies, to attend and vote online. The proxy materials explain the proposals, the voting rights attached to the common stock, and the board of directors’ recommendations on each proposal. The company also discusses procedures for stockholder proposals and the handling of proxy materials, such as householding of meeting materials.

Regulatory reporting and compliance

Profusa, Inc. files periodic and current reports with the SEC, including Forms 8-K, 10-Q, proxy statements on Schedule 14A, and notifications of late filing on Form 12b-25. These filings provide insight into the company’s financing arrangements, stockholder actions, and interactions with its listing exchange. For investors researching NVACW and related Profusa securities, these documents form the primary source of official information about the issuer’s regulatory status, capital transactions, and stockholder approvals.